Comparison of two multimarker serum tests for the prediction of ovarian cancer in women with a pelvic mass. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
JS207, Junshi Biosciences’ independently developed recombinant humanized anti-PD-1/VEGF bispecific antibody, has demonstrated promising anti-tumor activity and a manageable safety profile in both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results